MEDICAL ADVOCATES
IDUs
 
Global/National Harm Reduction Challenges

Global
Africa
Asia

Australia/Pacific Islands
Europe

Latin America/Caribbean
Middle East
North America
Russia/NIS


IDU Main Page Main New/Newsworthy  Home Page

Last Update:  December 18, 2014  
 
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

Global
               

          Journal Papers, Abstracts, and Commentaries
 
  Drug analysis of residual content of used syringes: A new approach for improving knowledge of injected drugs and drug user practices.
Néfau T, Charpentier E, Elyasmino N, et al
Int J Drug Policy
. 2014 Oct 2.
Abstract

Evaluation of HIV prevention interventions for people who inject drugs in low- and middle-income countries-The current and future state of the art.
Hammett TM, Parsons DS.
Int J Drug Policy. 2014 Jan 23.
Abstract
 

FULL-TEXT ARTICLE
Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries.
Petersen Z, Myers B, van Hout MC,
et al
Harm Reduct J
. 2013 Aug 19;10(1):13
Paper

A WEEK-IN-REVIEW FEATURED REPORT
FULL-TEXT ARTICLE

Pharmacists and harm reduction: A review of current practices and attitudes.
Watson T, Hughes C.

Can Pharm J (Ott). 2012 May;145(3):124-127.e2.
Paper

FULL-TEXT PDF ARTICLE
High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review.
Jarlais DC, Feelemyer JP, Modi SN, et al
BMC Public Health. 2013 Jan 19;13(1):5
Paper

Setting targets for universal access to HIV prevention, treatment and care for injecting drug users (IDUs): towards consensus and improved guidance.
Donoghoe MC, Verster A, Pervilhac C, Williams P.
Int J Drug Policy. 2008 Apr;19 Suppl 1:S5-14.
Abstract

   
          Conference Reports, Abstracts, and Posters
 
 
Multi-country harm reduction programming: the experience of Community Action on Harm Reduction
T. Deshko, S. McLean, S. Kushakov, ,et al
(XVIII International AIDS Conference)
Abstract

Does type of syringe influence HIV epidemics among injecting drug users?
W. Zule, S. Friedman, D. Des Jarlais.  et al
(XVIII International AIDS Conference)
Abstract

HIV, gender and IDUs: what works and the unfinished agenda
J. Gay, K. Hardee, M. Croce-Galis, et al
(XVIII International AIDS Conference)
Abstract

Syringe exchange programs around the world: the global context
S. Cahill
(XVIII International AIDS Conference)
Abstract

Issues in HIV prevention for injecting drug users (IDUs) in developing/transitional countries: Results from the WHO Phase II Drug injection study
D C Des Jarlais, T E Perlis, P Friedmann, et al

(15IAC)
Abstract


Africa
               

Mauritania
 
        Conference Reports, Abstracts, and Posters
 
  Harm reduction strategies in the Indian Ocean Region - the Mauritian experience
R. Ngmansun
(XVIII International AIDS Conference
Abstract
 
Tanzania
 
          Journal Papers, Abstracts, and Commentaries
 
  FULL TEXT ARTICLE
Identifying Programmatic Gaps: Inequities in Harm Reduction Service Utilization among Male and Female Drug Users in Dar es Salaam, Tanzania.
Lambdin BH, Bruce RD, Chang O, et al
PLoS One. 2013 Jun 25;8(6):e67062
Paper

An urgent need to scale-up injecting drug harm reduction services in Tanzania: Prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011.
Bowring AL, Luhmann N, Pont S,  et al
Int J Drug Policy. 2012 Oct 1.
Abstract

Tunisia
 

        Conference Reports, Abstracts, and Posters
 
  Surveillance of HIV prevention among drug users in Tunisia
A. Tammam
(XVIII International AIDS Conference
Abstract

Australia/Pacific Islands
               

Australia

          Journal Papers, Abstracts, and Commentaries

 
Extremely low and sustained HIV incidence among people who inject drugs in a setting of harm reduction.
Iversen J, Wand H, Topp L,  et al

AIDS
. 2013 Sep 19
Abstract

The cost of providing primary health-care services from a needle and syringe program: A case study.
Islam MM, Shanahan M, Topp L, et al

Drug Alcohol Rev
. 2012 Nov 29
Abstract

Estimating the cost-effectiveness of needle-syringe programs in Australia.
Kwon JA, Anderson J, Kerr CC
AIDS. 2012 Aug 18.
Abstract

Preventing transitions to injecting amongst young people: what is the role of Needle and Syringe Programmes?
Brener L, Spooner C, Treloar C.

Int J Drug Policy
. 2010 May;21(3):160-4
Abstract

The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia.
Salmon AM, van Beek I, Amin J,  et al
 
Addiction
. 2010 Apr;105(4):676-83
Abstract

Hepatitis C Virus Acquisition among Injecting Drug Users: A Cohort Analysis of a National Repeated Cross-sectional Survey of Needle and Syringe Program Attendees
in Australia, 1995-2004.
Falster K, Kaldor JM, Maher L 
J Urban Health. 2008 Nov
Abstract
 

The evaluation of a trial of syringe vending machines in Canberra, Australia
McDonald D.  
Int J Drug Policy. 2008 Sep 12.
Abstract
 
Assessing and prioritizing the preferences of injecting drug users in needle and syringe exchange service development.
Matheson C, Anthony GB, Bond C, Rossi MK.
J Public Health (Oxf). 2008 Apr 23
Abstract
 
The organization of a community: community-based prevention of injecting drug use-related healthproblems.
Carruthers S

Subst Use Misuse.
2007;42(12):1971-7.
Abstract
 
Harm minimization strategies: opinions of health professionals in rural and remote Australia.
Peterson GM, Northeast S, Jackson SL, Fitzmaurice KD. 
J Clin Pharm Ther. 2007 Oct;32(5):497-504.
Abstract
 
The effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settings.
Islam MM, Wodak A, Conigrave KM.
 
Int J Drug Policy.
2007 Aug 31;
Abstract
 
Comparison of needle and syringe programme attendees and non-attendees from a high drug-using area in Sydney, New South Wales
Cao W, Treloar C.  
Drug Alcohol Rev. 2006 Sep;25(5):439-44
Abstract
 
Threat or opportunity? Secondary exchange in a setting with widespread availability of needles.
Lenton S, Bevan J, Lamond T.  

Subst Use Misus
e. 2006;41(6-7):845-64.
Abstract
 
Effects of a sustained heroin shortage in three Australian States.
Degenhardt L, Day C, Dietze P, et al

Addiction. 2005 Jul;100(7):908-20.
Abstract
 
Randomized controlled trial of a brief behavioural intervention for reducing hepatitis | virus risk practices among injecting drug users.
Tucker T, Fry CL, Lintzeris N, et al 
Addiction
. 2004 Sep;99(9):1157-66.
Abstract

FULL-TEXT ARTICLE
Injecting drug use in Australia: needle/syringe programs prove their worth,but hepatitis C still on the increase.
Law MG, Batey RG.
 
Med J Aust
2003 Mar 3;178(5):197-8
Commentary

Vietnamese-speaking injecting drug users in Melbourne: the need for harm reduction
programs.
Louie R, Krouskos D, Gonzalez M, Crofts N.
Aust N Z J Public Health 1998 Jun;22(4):481-4
Abstract
 
 
        Conference Reports, Abstracts, and Posters
 
  Evaluating the cost-effectiveness of needle and syringe programs in Australia
D. Wilson, J. Kwon, J. Anderson, H.-H. Thein
(XVIII International AIDS Conference
Abstract

The Philippines

        Conference Reports, Abstracts, and Posters
 

  SHARP 4 IDUs: sidewalk psychotherapy enhances the efficacy of community outreach
Aquino C., D'Agnes L., Castro J
(XVI International AIDS Conference)
Abstract

Latin America/Caribbean
               

Multinational
 
        Conference Reports, Abstracts, and Posters
 
  POSTER
Supporting harm reduction in Latin America and the Caribbean (LAC)
P. Cymerman, M. Day, G. Hirnschall, R. Mazin
(XVIII International AIDS Conference)
PDF Poster    Abstract

Brazil

          Journal Papers, Abstracts, and Commentaries
 
  Decentralization, AIDS, and harm reduction: the implementation of public policies in Rio de Janeiro, Brazil.
Fonseca EM, Nunn A, Souza-Junior PB, et al
 
Cad Saude Publica.
2007 Sep;23(9):2134-44
Abstract
 

        Conference Reports, Abstracts, and Posters

  New approach to work with drug users in Sao Vicente City- Brazil
I E Maerrawi, R B Gomes, S B A Theodósio,  et al

(15IAC)
Abstract
 
Prevention of HIV infection in new initiators street-recruited Injection Drug Users (IDUs)
A C S Lopes, W T Caiaffa, SA Mignot
i, et al
(15IAC)
Abstract
 
Development and challenges in the enlargement of preventive actions towards the most vulnerable populations (men who have sex with men MSM, intravenous drug users IDU, sex workers SW and low income population ) in the state of Sao Paulo, Brazil
C W Westin, M G Giovanetti, A Y Yamaçake, et al

(15IAC)
Abstract
 

Mexico

          Journal Papers, Abstracts, and Commentaries
 
 
Over-the-Counter But Out of Reach: A Pharmacy-Based Survey of OTC Syringe Sales in Tijuana, Mexico.
Pollini RA, Gallardo M, Ruiz S,  et a
l
J Health Care Poor Underserved
. 2014;25(2):637-51
Abstract

Negotiating access: Social barriers to purchasing syringes at pharmacies in Tijuana, Mexico.
Davidson PJ, Lozada R, Rosen PC,  et al

Int J Drug Policy
. 2012 Jun 5.
Abstract

FULL-TEXT PDF ARTICLE
Not Sold Here: Limited Access to Legally Available Syringes at Pharmacies in
Tijuana, Mexico

Pollini RA,  Rosen PC, Gallardo M,  et al
Harm Reduction Journal
2011, 8:13
Paper

Exploring stakeholder perceptions of acceptability and feasibility of needle exchange programmes, syringe vending machines and safer injection facilities in Tijuana, Mexico.
Philbin MM, Mantsios A, Lozada R, et al 
Int J Drug Policy. 2008 Oct 27
Abstract

        Conference Reports, Abstracts, and Posters

 
Factors associated with barriers to pharmacy-based syringe purchase among injection drug users (IDUs) in Tijuana, Mexico
R.A. Pollini, J. Alvelais, R. Lozada, et al
(XVII International AIDS Conference)
Abstract
 
Predictors of needle exchange program utilization during its implementation and
expansion in Tijuana, Mexico

S. Strathdee, R. Lozada, C. Magis-Rodriguez, et al
(XVII International AIDS Conference)
Abstract

High prevalence of Injecting drug users HIV/AIDS and risk practices in one Mexican city
C Magis, R Ortiz, S Noriega, M E Ramos

(15IAC)
Abstract


Puerto Rico

          Journal Papers, Abstracts, and Commentaries

 
Puerto Rican injection drug users: Prevention implications in Massachusetts and
Puerto Rico.
López LM, Zerden LD, Fitzgerald TC, Lundgren LM.

Eval Program Plann.
2007 Jul 7;
Abstract

Effects of combined counseling and case management to reduce HIV risk behaviors among Hispanic drug injectors in Puerto Rico: A randomized controlled study.
Robles RR, Reyes JC, Colon HM
 
J Subst Abuse Treat.
2004 Sep;27(2):145-152.
Abstract


Middle East
       

Afghanistan
 
          Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT PDF ARTICLE
Prevalence and correlates of HIV, syphilis, and hepatitis B and C infection and harm reduction program use among male injecting drug users in Kabul, Afghanistan: A cross-sectional assessment.
Todd CS, Nasir A, Stanekzai MR, et al 

Harm Reduct
J
. 2011 Aug 25;8(1):22.

Paper

A qualitative assessment of injection drug use and harm reduction programmes in Kabul,
Afghanistan: 2006-2007.

Todd CS, Stibich MA, Stanekzai MR, et al

Int J Drug Policy
. 2008 Jan 18
Abstract

Iran

          Journal Papers, Abstracts, and Commentaries

  Access to harm reduction programs among persons who inject drugs: Findings from a respondent-driven sampling survey in Tehran, Iran.
Rahnama R, Mohraz M, Mirzazadeh A. et al

Int J Drug Policy
. 2014 Jun 2.

Abstract

Transition to injection amongst opioid users in Iran: Implications for harm reduction.
Malekinejad M, Vazirian M.
Int J Drug Policy. 2011 Oct 12.
Abstract

FULL-TEXT PDF ARTICLE
Needle and syringe sharing practices of injecting drug users participating in an outreach HIV prevention program in Tehran, Iran: A cross-sectional study.
Vazirian M, Nassirimanesh B, Zamani S, et al 

Harm Reduct J.
2005 Oct 7;2(1):19
Paper

        Conference Reports, Abstracts, and Posters

 
HIV prevention programmes among injecting drug users in Iran: from pilot to scale up
M. Taj , S. Sefatian, G. Mostashari, A. Feizzadeh
(XVII International AIDS Conference)
Abstract
 
Harm reduction among positive injecting drug users
V. Nowbahar , E. Matlabi
(XVII International AIDS Conference)
Abstract

The role of IV drug users control in prevention of AIDS
M G Ghanbari, E M Esmaeelzade

(15IAC)
Abstract

Israel
 
          Journal Papers, Abstracts, and Commentaries
 
  "Injecting clean or being clean?" The international and Israeli experiences of Syringe Exchange Programs among injecting drug users
Chemtob D, Levit S, Mell H, et al   
Harefuah. 2008 Jul;147(7):634-8,
Abstract|
 
Kazakhstan
 
          Journal Papers, Abstracts, and Commentaries
 
  Couple-based HIV prevention for injecting drug users in Kazakhstan: a pilot intervention study.
Gilbert L, El-Bassel N, Terlikbayeva A, et al

J Prev Interv Community. 2010 Apr;38(2):162-76.
Abstract
 
Lebanon
 
  HIV/AIDS/STI prevention targeting IDUs in Lebanon 2008-2009
B. Nadia
(XVIII International AIDS Conference)
Abstract
Kazakhstan
 
  Advancing an evidence-based integrated HIV and overdose prevention intervention for injecting Zdrug-involved couples in Kazakhstan: project renaissance
L. Gilbert, N. El-Bassel, A. Terlikbayeva, M. Khassanova
(XVIII International AIDS Conference)
Abstract
 
Kyrgyzstan
 
  Cooperation with the police, to create a conducive environment for harm reduction services
R. Berg
(XVIII International AIDS Conference)
Abstract

Pakistan

          Journal Papers, Abstracts, and Commentaries

  Coverage to curb the emerging HIV epidemic among injecting drug users in Pakistan: delivering prevention services where most needed.
Emmanuel F, Fatima M .
Int J Drug Policy. 2008 Apr;19 Suppl 1:S59-64.
Abstract
 
        Conference Reports, Abstracts, and Posters
  Harm reduction among injection drug users in Karachi, Pakistan
A Altaf, A Me
mon, N Rehman, S S A Shah
(15IAC)
Abstract
 
Use of different interventions for decreasing HIV transmission among drug users in Pakistan
A Akhtar, M Aslam, M I Zafar

(15IAC)
Abstract
 
Uzbekistan
 
        Conference Reports, Abstracts, and Posters
 
  Evaluation of the harm reduction program efficiency among injecting drug users in Uzbekistan
E. Mun, N. Atabekov, S. Kolemasova, L. Mun
(XVIII International AIDS Conference)
Abstract

Russia/New Independent States
       

Belarus

          Journal Papers, Abstracts, and Commentaries
 
  The cost-effectiveness of HIV preventive measures among injecting drug users in Svetlogorsk, Belarus.
Kumaranayake L, Vickerman P, Walker D, et al  

Addiction. 2004 Dec;99(12):1565-76
Abstract
 
Bulgaria

          Journal Papers, Abstracts, and Commentaries

  Needle exchange use, sexual risk behaviour, and the prevalence of HIV, hepatitis B virus, and hepatitis C virus infections among Bulgarian injection drug users.
Vassilev ZP, Hagan H, Lyubenova A, Tomov N, et al
Int J STD AIDS. 2006 Sep;17(9):621-6.
Abstract
 
Croatia

        Conference Reports, Abstracts, and Posters
 

  First quality of life study of IDUs in Croatia
Jovovic I., Fiser S., Ogresta J.
(XVI International AIDS Conference)
Abstract
 
Estonia
 
       Journal Papers, Abstracts, and Commentaries
 
  Commentary on Vorobjov et al., "Comparison of injection drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia"
Werb D, Wood E.
Harm Reduct J. 2009 Nov 27;6(1):33.
Abstract

Georgia
 

       Journal Papers, Abstracts, and Commentaries
 
 
Why Do the Clients of Georgian Needle Exchange Programmes Inject Buprenorphine?
Otiashvili D, Zabransky T, Kirtadze I, et al

Eur Addict Res
. 2009 Nov 2;16(1):1-8
Abstract

Implementation of drug substitution therapy in Georgia.
Todadze K, Lezhava G.

Cent Eur J Public Health. 2008 Sep;16(3):121-3.
Abstract
 

Latvia

        Conference Reports, Abstracts, and Posters
 

  Influence of the coordinated harm reduction activities through the network of outreach counselling centres on injecting and sexual behaviour of IDUs in Latvia
Skripste I., Upmace I., Bulmistre I., et al
(XVI International AIDS Conference)
Abstract

 

Russia

          Journal Papers, Abstracts, and Commentaries

 
A Peer-Educator Network HIV Prevention Intervention Among Injection Drug Users: Results of a Randomized Controlled Trial in St. Petersburg, Russia.
Hoffman IF, Latkin CA, Kukhareva PV, Malov SV, et al
AIDS Behav. 2013 Sep;17(7):2510-20
Abstract

FULL-TEXT ARTICLE
Development of Combination HIV Prevention Programs for People Who Inject Drugs through Government and Civil Society Collaboration in the Russian Federation.
Volik MV, Karmanova GA, Berezina EB, et al
Adv Prev Med. 2012;2012:874615
Paper

Access to syringes in three Russian cities: Implications for syringe distribution and coverage.
Sarang A, Rhodes T, Platt L. 
Int J Drug Policy. 2008 Feb 28
Abstract

Injecting Equipment Sharing Among Injecting Drug Users in Togliatti City, Russian Federation: Maximizing the Protective Effects of Syringe Distribution.
Rhodes T, Judd A, Mikhailova L, et al

J Acquir Immune Defic Syndr.
2004 Apr 12;35(3):293-300.
Abstract

        Conference Reports, Abstracts, and Posters

 
POSTER
Harm reduction among drug users from conclusive medicine point of view
E. Demyanenko
(XVIII International AIDS Conference)
PDF Poster    Abstract

 
POSTER
HIV prevention for people who use drugs: studying the opportunities of integrating prevention programs and the activity of social, medical and other services
L. Khalabuda, R. Sadykova, I. Jekabsone, et al
(XVIII International AIDS Conference)
PDF Poster    Abstract

 
Drug users' perceptions of HIV prevention programs in North West Russia
P. Meylakhs, A. Aasland, A.B. Groenningsaeter
(XVIII International AIDS Conference)
Abstract
 
How taking care of oneself could help long term injection drug users remain uninfected with HIV and HCV
P. Meylakhs, S.R. Friedman, P. Mateu-Gelabert, et al
(XVIII International AIDS Conference)
Abstract

HIV-prevention in emergency department (ED) and injecting drug users (IDUs)
S K Sarmanaev
(
XV International AIDS Conference)
Abstract

Ukraine

         Journal Papers, Abstracts, and Commentaries

 

FULL-TEXT ARTICLE
Effectiveness and Cost Effectiveness of Oral Pre-Exposure Prophylaxis in a Portfolio of Prevention Programs for Injection Drug Users in Mixed HIV Epidemics.
Alistar SS, Owens DK, Brandeau ML. et al

PLoS One
. 2014 Jan 28;9(1):e86584.
Paper

Rejuvenating harm reduction projects for injection drug users: Ukraine's nationwide introduction of peer-driven interventions.
Smyrnov P, Broadhead RS, Datsenko O, Matiyash O.

Int J Drug Policy
. 2012 Mar;23(2):141-7
Abstract

The Cost-Effectiveness of Expanding Harm Reduction Activities for Injecting Drug Users in Odessa, Ukraine.
Vickerman P, Kumaranayake L, Balakireva O, et al 
Sex Transm Dis. 2006 May 25;
Abstract
 

        Conference Reports, Abstracts, and Posters
 
 
Ensuring safety in the context of new needle and syringe programs in the community
S. Ayo, Ndimbii, O. Mlewa, M. Braga
(XX International AIDS Conference)
Abstract

Comprehensive harm reduction programs reduce risk behaviours and HIV prevalence among IDUs
V. Isakov
(XIX International AIDS Conference)
Abstract

Prevention of HIV spread in Ukraine through the expansion of substitution treatment is lacking contributions from state budget
T. Perepelytsia, S. Filippovych, Z. Islam, O. Lebega
(XVIII International AIDS Conference)
Abstract

Condoms-related stereotypes as a restraint of IDU women´s right to safe sex in Ukraine
K. Maksymenko, A. Dovbakh, M. Varban
(XVIII International AIDS Conference)
Abstract

 
Harm reduction as a basis for integrated services to prevent HIV among drug users
P. Smyrnov, L. Shulga
(XVIII International AIDS Conference)
Abstract
 
Home-based care and rehabilitation for people living with HIV (PLHIV) and injecting drug users (IDUs) done by trained Red Cross nurses - the most needed alternative to save lives: Ukraine
harm reduction experience
S. Mnatsakanova, J. Pletsch
(XVIII International AIDS Conference)
Abstract

Long-term PDI contribution to coverage of harm reduction projects in Ukraine
O. Datsenko, O. Matiyash
(XVIII International AIDS Conference)
Abstract

The integration and comprehensiveness of HIV prevention, treatment and care programs for injecting drug users in Ukraine
I. Oliynyk
(XVII International AIDS Conference)
Abstract


IDU Main Page Main New/Newsworthy  Home Page

IDU Infectious Disease Prevention/Reduction Challenges